Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kristopher Wentzel"'
Autor:
Vivek Subbiah, Neeraj Agarwal, Sumanta Pal, Amita Patnaik, Manish Sharma, Edward Cha, Geoffrey Shapiro, Kristopher Wentzel, Elizabeth McIlvaine, Jana Waldes, Keyvan Tadjalli-Mehr
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/a4599c8ac2e342e7bade577ce70d76ae
Autor:
Matthew Galsky, Karen Autio, Kristopher Wentzel, Julie Graff, Terence Friedlander, Julie Densmore, Christopher Cabanski, Kristin Shotts, Tim Howes, Jia Yu, Elaine Eisenbeisz, Marko Spasic, Stephen Maddock, Diane DaSilva, Dinesh Kumar, Jonni Moore, Richard Schretzenmair, Jennifer Lata, Arron Xu, Emma Reuschel, Snehal Wani, Matthew Morrow, Jeffrey Skolnik, Sandra Santulli-Marotto, Lacey Padron, Lisa Butterfield, Theresa LaVallee, Samantha Bucktrout, Michael Yellin, Tibor Keler, Lisa Salvador, Jill O'Donnell-Tormey, Vanessa Lucey, Justin Fairchild, Ute Dugan, Nina Bhardwaj, Sumit Subudhi, Lawrence Fong
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Kristin Shotts, Timothy Howes, Jia Yu, Julie Densmore, Diane Da Silva, Dinesh Kumar, Sandra Santulli-Marotto, Christopher Cabanski, Elaine Eisenbeisz, Geoffrey Ivison, Aaron Mayer, Jonni Moore, Derek Jones, Kimberly Kraynyak, Alex Dolgoter, Richard Chen, Lisa Butterfield, Theresa LaVallee, Samantha Bucktrout, Lacey Padron, Ute Dugan, Michael Yellin, Tibor Keler, Jill O'Donnell-Tormey, Justin Fairchild, Lisa Salvador, Kristopher Wentzel, Lawrence Fong, Sumit Subudhi, Nina Bhardwaj, Karen Autio, Matthew Galsky
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Kristopher Wentzel, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Li Ding, Evan Pisick, Mridula Krishnan, Deepti Behl, Olatunji B. Alese, Carmen J. Calfa, Kathrine A. Cooper, Herbert L. Duvivier, Raghava Reddy Induru, Janet C. Ruzich, Song Zhao, Gina N. Grantham, Abigail Gregory, Susan Halabi, Richard L. Schilsky
Publikováno v:
Cancer Research. 83:CT231-CT231
Background: TAPUR is a phase II basket study evaluating antitumor activity of commercially available targeted agents in pts with advanced cancers with specific genomic alterations. Results in a cohort of pts with solid tumors with PTEN mut treated wi
Autor:
Artak Labadzhyan, Kristopher Wentzel, Omid Hamid, Kamlynn Chow, Sungjin Kim, Lawrence Piro, Shlomo Melmed
Publikováno v:
J Clin Endocrinol Metab
Context Incidence and awareness of endocrine-related adverse events (ERAE) associated with use of immune checkpoint inhibitors (ICI) has grown with increased ICI use, yet mechanisms for ERAE prediction, surveillance, and development are not well esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e98d0cae8e98e3df78860e6593a6ac3
https://europepmc.org/articles/PMC9202695/
https://europepmc.org/articles/PMC9202695/
Autor:
Amita Patnaik, Keyvan Tadjalli-Mehr, Geoffrey I. Shapiro, Kristopher Wentzel, Edward Cha, Jana Waldes, Manish Sharma, Sumanta K. Pal, Jing Li, Elizabeth Mcilvaine, Neeraj Agarwal, Vivek Subbiah
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundXL092 is a novel oral multi-targeted inhibitor of receptor tyrosine kinases. In preclinical studies, oral dosing with XL092 resulted in pharmacodynamic inhibition of MET, TAM kinases (AXL, MER), and VEGFR2 phosphorylation and was associated
Autor:
Manish Sharma, Vivek Subbiah, Geoffrey Shapiro, Sumanta K. Pal, Neeraj Agarwal, Kristopher Wentzel, Saswati Hazra, Rashmi Vora, Jana Waldes, Edward Cha, Keyvan Tadjalli Mehr, Amita Patnaik
Publikováno v:
Journal of Clinical Oncology. 40:TPS401-TPS401
TPS401 Background: XL092 is a novel oral multi-targeted inhibitor of receptor tyrosine kinases MET, VEGFR2, and TAM kinases (AXL, MER), which are important in tumor growth, neovascularization, and immune modulation of the tumor microenvironment. XL09
Autor:
Laura Catherine Farrington, Alissa S. Marr, Stacy D. D'Andre, Scott M. Schuetze, Margaret von Mehren, Carmen Calfa, Michael Rothe, Michael B. Livingston, Pam K. Mangat, Funda Meric-Bernstam, Richard L. Schilsky, Ramya Thota, Liz Garrett-Mayer, Kristopher Wentzel
Publikováno v:
Journal of Clinical Oncology. 39:11565-11565
11565 Background: TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations. Results in a cohort of STS pts with CDK4 amplification treated with P a
Autor:
Tanya B. Dorff, Jacek Pinski, Brian Hu, Inderbir S. Gill, Yucheng Xu, Paul W. Dempsey, Amir Goldkorn, Jessamine Winer Jones, David I. Quinn, Stephen V. Liu, William Strauss, Kristopher Wentzel, Tong Xu, Timothy J. Triche
Publikováno v:
Journal of Urology. 193
Autor:
William Strauss, Tanya B. Dorff, Jessamine Winer-Jones, Kristopher Wentzel, Yucheng Xu, Paul W. Dempsey, Tong Xu, Stephen V. Liu, David I. Quinn, Jacek Pinski, Brian Hu, Amir Goldkorn
Publikováno v:
Cancer Research. 75:1587-1587
Introduction: Precision oncology care is predicated upon detecting actionable genomic aberrations. Obtaining tissue that accurately reflects the genomic landscape of prostate cancer (PCa) is a challenge, though circulating tumor cells (CTCs) represen